AI Portfolio Summary
In 2025 Q4, SUPERSTRING CAPITAL MANAGEMENT LP maintained a portfolio of 64 distinct positions. The most significant new addition to the portfolio was DYNAVAX TECHNOLOGIES, which now represents 4.33% of the total fund value. They heavily accumulated shares in CIDARA THERAPEUTICS , increasing their position by 24.3%. Conversely, SUPERSTRING CAPITAL MANAGEMENT LP completely exited their position in I MAB.
Total Positions
64
Quarter
2025 Q4
Top Holding
CDTX (10.1%)
Top 10 Concentration
57.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 64
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CDTX
CIDARA THERAPEU...
|
Healthcare | 10.06% | 6.46% |
#1
1
Prev: #2
|
8.5 | 16,635 | 24.3% |
P
S
|
85,098 | $18,797,297 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TERN
TERNS PHARMACEU...
|
Healthcare | 9.60% | 5.84% |
#2
1
Prev: #3
|
5.3 | -345,869 | -43.8% |
P
S
|
443,777 | $17,928,591 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
URGN
UROGEN PHARMA L...
|
Healthcare | 9.01% | 1.73% |
#3
20
Prev: #23
|
7.6 | 630,442 | 717.1% |
P
S
|
718,354 | $16,823,851 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 6.96% | 5.11% |
#4
3
Prev: #7
|
3.8 | 4,830 | 1.3% |
P
S
|
366,238 | $13,008,774 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DVAX
DYNAVAX TECHNOL...
|
Healthcare | 4.33% | — |
#5
Prev: #—
|
5.7 | 525,592 | no change |
NEW
|
525,592 | $8,083,605 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SION
SIONNA THERAPEU...
|
Healthcare | 3.98% | — |
#6
Prev: #—
|
5.1 | 180,593 | no change |
NEW
|
180,593 | $7,429,596 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 3.93% | 5.42% |
#7
2
Prev: #5
|
2.1 | -52,671 | -15.4% |
P
S
|
288,677 | $7,338,169 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 3.66% | — |
#8
Prev: #—
|
5.0 | 37,433 | no change |
NEW
|
37,433 | $6,836,763 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SVRA
SAVARA INC
|
Healthcare | 3.21% | 4.60% |
#9
1
Prev: #8
|
1.3 | -313,883 | -24.0% |
P
S
|
995,353 | $6,001,979 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MNMD
MIND MEDICINE M...
|
Healthcare | 3.05% | — |
#10
Prev: #—
|
4.7 | 425,202 | no change |
NEW
|
425,202 | $5,693,455 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TSHA
TAYSHA GENE THE...
|
Healthcare | 2.89% | — |
#11
Prev: #—
|
4.7 | 980,768 | no change |
NEW
|
980,768 | $5,394,224 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OCUL
OCULAR THERAPEU...
|
Healthcare | 2.72% | — |
#12
Prev: #—
|
4.6 | 418,080 | no change |
NEW
|
418,080 | $5,075,491 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FOLD
AMICUS THERAPEU...
|
Healthcare | 2.69% | — |
#13
Prev: #—
|
4.6 | 352,896 | no change |
NEW
|
352,896 | $5,025,239 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CABA
CABALETTA BIO I...
|
Healthcare | 2.64% | 3.56% |
#14
2
Prev: #12
|
3.6 | 709,025 | 45.9% |
P
S
|
2,253,550 | $4,935,275 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 2.47% | — |
#15
Prev: #—
|
4.5 | 9,451 | no change |
NEW
|
9,451 | $4,605,000 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 2.34% | — |
#16
Prev: #—
|
4.4 | 54,879 | no change |
NEW
|
54,879 | $4,371,112 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BLTE
BELITE BIO INC
|
Healthcare | 2.12% | — |
#17
Prev: #—
|
4.3 | 24,703 | no change |
NEW
|
24,703 | $3,951,492 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DRUG
BRIGHT MINDS BI...
|
Healthcare | 1.98% | 3.22% |
#18
4
Prev: #14
|
1.3 | -6,672 | -12.4% |
P
S
|
47,278 | $3,689,575 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZLAB
ZAI LAB LTD
|
Healthcare | 1.86% | 6.70% |
#19
18
Prev: #1
|
1.2 | -3,775 | -1.9% |
P
S
|
196,853 | $3,472,487 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZBIO
ZENAS BIOPHARMA...
|
Healthcare | 1.62% | 2.11% |
#20
Prev: #20
|
1.1 | -13,312 | -13.8% |
P
S
|
83,353 | $3,026,547 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
QNCX
QUINCE THERAPEU...
|
Healthcare | 1.54% | — |
#21
Prev: #—
|
4.1 | 858,711 | no change |
NEW
|
858,711 | $2,876,682 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 1.49% | 2.36% |
#22
4
Prev: #18
|
1.1 | -34,767 | -18.5% |
P
S
|
153,313 | $2,784,164 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CAPR
CAPRICOR THERAP...
|
Healthcare | 1.49% | — |
#23
Prev: #—
|
4.1 | 96,334 | no change |
NEW
|
96,334 | $2,780,199 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PVLA
PALVELLA THERAP...
|
Healthcare | 1.43% | — |
#24
Prev: #—
|
4.1 | 25,469 | no change |
NEW
|
25,469 | $2,665,840 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 1.28% | — |
#25
Prev: #—
|
4.0 | 88,308 | no change |
NEW
|
88,308 | $2,398,445 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ASMB
ASSEMBLY BIOSCI...
|
Healthcare | 1.19% | — |
#26
Prev: #—
|
4.0 | 65,273 | no change |
NEW
|
65,273 | $2,219,935 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 1.12% | 1.06% |
#27
2
Prev: #29
|
3.4 | 166,024 | 185.8% |
P
S
|
255,370 | $2,088,927 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TARA
PROTARA THERAPE...
|
Healthcare | 1.03% | 1.54% |
#28
4
Prev: #24
|
1.4 | no change | no change |
P
S
|
360,000 | $1,918,800 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TRVI
TREVI THERAPEUT...
|
Healthcare | 0.99% | — |
#29
Prev: #—
|
3.9 | 148,292 | no change |
NEW
|
148,292 | $1,856,616 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TYRA
TYRA BIOSCIENCE...
|
Healthcare | 0.83% | — |
#30
Prev: #—
|
3.8 | 58,677 | no change |
NEW
|
58,677 | $1,542,618 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 0.78% | 1.26% |
#31
3
Prev: #28
|
0.3 | -15,605 | -29.1% |
P
S
|
38,022 | $1,452,821 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 0.72% | — |
#32
Prev: #—
|
3.8 | 43,230 | no change |
NEW
|
43,230 | $1,345,318 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RZLT
REZOLUTE INC
|
Healthcare | 0.65% | — |
#33
Prev: #—
|
3.8 | 513,765 | no change |
NEW
|
513,765 | $1,212,485 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 0.58% | — |
#34
Prev: #—
|
3.7 | 26,249 | no change |
NEW
|
26,249 | $1,081,721 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SPRB
SPRUCE BIOSCIEN...
|
Healthcare | 0.57% | — |
#35
Prev: #—
|
3.7 | 12,137 | no change |
NEW
|
12,137 | $1,057,254 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AARD
AARDVARK THERAP...
|
Healthcare | 0.49% | — |
#36
Prev: #—
|
3.7 | 69,496 | no change |
NEW
|
69,496 | $912,135 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GMAB
GENMAB A/S
|
Healthcare | 0.48% | — |
#37
Prev: #—
|
3.7 | 29,162 | no change |
NEW
|
29,162 | $898,190 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PALI
PALISADE BIO IN...
|
Healthcare | 0.46% | — |
#38
Prev: #—
|
3.7 | 367,103 | no change |
NEW
|
367,103 | $862,692 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FULC
FULCRUM THERAPE...
|
Healthcare | 0.44% | — |
#39
Prev: #—
|
3.7 | 72,060 | no change |
NEW
|
72,060 | $814,999 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 0.39% | — |
#40
Prev: #—
|
3.7 | 31,738 | no change |
NEW
|
31,738 | $729,974 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PTN
PALATIN TECHNOL...
|
Healthcare | 0.28% | — |
#41
Prev: #—
|
3.6 | 33,971 | no change |
NEW
|
33,971 | $522,474 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IVA
INVENTIVA SA
|
Healthcare | 0.25% | — |
#42
Prev: #—
|
3.6 | 100,000 | no change |
NEW
|
100,000 | $465,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IPSC
CENTURY THERAPE...
|
Healthcare | 0.25% | 0.23% |
#43
8
Prev: #35
|
1.1 | no change | no change |
P
S
|
462,963 | $460,556 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BMEA
BIOMEA FUSION I...
|
Healthcare | 0.17% | 0.50% |
#44
10
Prev: #34
|
1.1 | no change | no change |
P
S
|
250,000 | $310,000 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ENTX
ENTERA BIO LTD
|
Healthcare | 0.02% | — |
#45
Prev: #—
|
3.5 | 17,142 | no change |
NEW
|
17,142 | $33,255 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMAB
I MAB
|
Unknown | 0.00% | 0.52% |
Sold All 😨
(Was: #33) |
0.0 | -139,886 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CRBP
CORBUS PHARMACE...
|
Healthcare | 0.00% | 0.72% |
Sold All 😨
(Was: #32) |
0.0 | -57,644 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VIR
VIR BIOTECHNOLO...
|
Healthcare | 0.00% | 0.85% |
Sold All 😨
(Was: #31) |
0.0 | -150,312 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RAPT
RAPT THERAPEUTI...
|
Healthcare | 0.00% | 0.88% |
Sold All 😨
(Was: #30) |
0.0 | -34,449 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PTGX
PROTAGONIST THE...
|
Healthcare | 0.00% | 1.33% |
Sold All 😨
(Was: #27) |
0.0 | -20,358 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-50 of 64 holdings